HEALTH IN TECH INC-CLASS A (HIT) Fundamental Analysis & Valuation

NASDAQ:HIT • US42217D1028

Current stock price

1.8 USD
-0.2 (-10%)
At close:
1.8018 USD
+0 (+0.1%)
After Hours:

This HIT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. HIT Profitability Analysis

1.1 Basic Checks

  • HIT had positive earnings in the past year.
  • HIT had a positive operating cash flow in the past year.
HIT Yearly Net Income VS EBIT VS OCF VS FCFHIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

  • HIT's Return On Assets of 6.32% is amongst the best of the industry. HIT outperforms 87.84% of its industry peers.
  • HIT's Return On Equity of 8.38% is on the low side compared to the rest of the industry. HIT is outperformed by 60.14% of its industry peers.
  • HIT has a better Return On Invested Capital (5.83%) than 81.08% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HIT is below the industry average of 15.41%.
  • The 3 year average ROIC (12.86%) for HIT is well above the current ROIC(5.83%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.32%
ROE 8.38%
ROIC 5.83%
ROA(3y)8.69%
ROA(5y)N/A
ROE(3y)15.98%
ROE(5y)N/A
ROIC(3y)12.86%
ROIC(5y)N/A
HIT Yearly ROA, ROE, ROICHIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40

1.3 Margins

  • The Profit Margin of HIT (4.68%) is worse than 68.92% of its industry peers.
  • HIT's Operating Margin of 4.50% is on the low side compared to the rest of the industry. HIT is outperformed by 81.76% of its industry peers.
  • HIT's Gross Margin of 67.07% is amongst the best of the industry. HIT outperforms 95.95% of its industry peers.
Industry RankSector Rank
OM 4.5%
PM (TTM) 4.68%
GM 67.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIT Yearly Profit, Operating, Gross MarginsHIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. HIT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HIT is creating some value.
  • HIT has more shares outstanding than it did 1 year ago.
  • HIT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HIT Yearly Shares OutstandingHIT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
HIT Yearly Total Debt VS Total AssetsHIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • HIT has an Altman-Z score of 14.61. This indicates that HIT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 14.61, HIT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • There is no outstanding debt for HIT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.61
ROIC/WACC0.66
WACC8.85%
HIT Yearly LT Debt VS Equity VS FCFHIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

  • A Current Ratio of 2.87 indicates that HIT has no problem at all paying its short term obligations.
  • The Current ratio of HIT (2.87) is better than 91.22% of its industry peers.
  • HIT has a Quick Ratio of 2.87. This indicates that HIT is financially healthy and has no problem in meeting its short term obligations.
  • HIT has a better Quick ratio (2.87) than 91.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.87
HIT Yearly Current Assets VS Current LiabilitesHIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HIT Growth Analysis

3.1 Past

  • The earnings per share for HIT have decreased strongly by -55.43% in the last year.
  • HIT shows a decrease in Revenue. In the last year, the revenue decreased by -8.93%.
EPS 1Y (TTM)-55.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)-8.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 148.53% on average over the next years. This is a very strong growth
  • HIT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 60.72% yearly.
EPS Next Y21.2%
EPS Next 2Y-55.05%
EPS Next 3Y148.54%
EPS Next 5YN/A
Revenue Next Year67.75%
Revenue Next 2Y47.59%
Revenue Next 3Y60.72%
Revenue Next 5YN/A

3.3 Evolution

HIT Yearly Revenue VS EstimatesHIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
HIT Yearly EPS VS EstimatesHIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 90.00, the valuation of HIT can be described as expensive.
  • Based on the Price/Earnings ratio, HIT is valued more expensive than 83.78% of the companies in the same industry.
  • HIT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • HIT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 90
Fwd PE N/A
HIT Price Earnings VS Forward Price EarningsHIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HIT is valued a bit more expensive than 69.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 52.66
HIT Per share dataHIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HIT's earnings are expected to grow with 148.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.25
PEG (5Y)N/A
EPS Next 2Y-55.05%
EPS Next 3Y148.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIT Dividend Analysis

5.1 Amount

  • HIT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIT Fundamentals: All Metrics, Ratios and Statistics

HEALTH IN TECH INC-CLASS A

NASDAQ:HIT (3/20/2026, 8:00:01 PM)

After market: 1.8018 +0 (+0.1%)

1.8

-0.2 (-10%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-10
Earnings (Next)03-25
Inst Owners4.79%
Inst Owner Change68.63%
Ins Owners74.38%
Ins Owner Change7.23%
Market Cap102.44M
Revenue(TTM)30.72M
Net Income(TTM)1.44M
Analysts80
Price Target4.59 (155%)
Short Float %1.61%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.53%
Min Revenue beat(2)15.6%
Max Revenue beat(2)23.46%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-166.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 90
Fwd PE N/A
P/S 3.33
P/FCF N/A
P/OCF 47.61
P/B 5.97
P/tB 9.33
EV/EBITDA 52.66
EPS(TTM)0.02
EY1.11%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.04
OCFY2.1%
SpS0.54
BVpS0.3
TBVpS0.19
PEG (NY)4.25
PEG (5Y)N/A
Graham Number0.37
Profitability
Industry RankSector Rank
ROA 6.32%
ROE 8.38%
ROCE 7.89%
ROIC 5.83%
ROICexc 10.77%
ROICexgc 30.87%
OM 4.5%
PM (TTM) 4.68%
GM 67.07%
FCFM N/A
ROA(3y)8.69%
ROA(5y)N/A
ROE(3y)15.98%
ROE(5y)N/A
ROIC(3y)12.86%
ROIC(5y)N/A
ROICexc(3y)19.87%
ROICexc(5y)N/A
ROICexgc(3y)65.42%
ROICexgc(5y)N/A
ROCE(3y)20.71%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 473.62%
Cap/Sales 9.65%
Interest Coverage 250
Cash Conversion 107.09%
Profit Quality N/A
Current Ratio 2.87
Quick Ratio 2.87
Altman-Z 14.61
F-Score5
WACC8.85%
ROIC/WACC0.66
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)10.58%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y21.2%
EPS Next 2Y-55.05%
EPS Next 3Y148.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.41%
Revenue Next Year67.75%
Revenue Next 2Y47.59%
Revenue Next 3Y60.72%
Revenue Next 5YN/A
EBIT growth 1Y-70.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year275.49%
EBIT Next 3Y159.05%
EBIT Next 5YN/A
FCF growth 1Y231.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.34%
OCF growth 3YN/A
OCF growth 5YN/A

HEALTH IN TECH INC-CLASS A / HIT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEALTH IN TECH INC-CLASS A (HIT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIT.


What is the valuation status of HEALTH IN TECH INC-CLASS A (HIT) stock?

ChartMill assigns a valuation rating of 1 / 10 to HEALTH IN TECH INC-CLASS A (HIT). This can be considered as Overvalued.


What is the profitability of HIT stock?

HEALTH IN TECH INC-CLASS A (HIT) has a profitability rating of 3 / 10.


Can you provide the financial health for HIT stock?

The financial health rating of HEALTH IN TECH INC-CLASS A (HIT) is 9 / 10.


Can you provide the dividend sustainability for HIT stock?

The dividend rating of HEALTH IN TECH INC-CLASS A (HIT) is 0 / 10 and the dividend payout ratio is 0%.